Loading…
Makes precision injection-molded plastic components — drug-delivery devices, FMCG packaging and consumer products — in India.
Makes precision injection-molded plastic components — drug-delivery devices, FMCG packaging and consumer products — in India.
Makes molded parts to its customers' own designs under multi-year programmes, so a pen or inhaler component qualified for a drug maker's product tends to be made by the same supplier for years. Its growth in pharma devices comes from drug makers outsourcing the manufacture of injectable pen devices.
Moat: narrow (process know-how, customer qualification). Precision molding qualification for pharma devices is technical, but global device makers like Gerresheimer are far larger.
Headquarters: Vadodara, India · Founded: 1994 · Employees: 3,202
Size Shaily Engineering Plastics (SHAILY.NS) is an India Materials company (Chemicals: Specialty) with a market value of $1.48B, the 474th largest of 1,058 India companies the cockpit tracks. Shares closed at ₹3,046 on 6 Nov 2026.
Performance Over six months the shares gained 13.9%, against -26.3% for the median peer and 0.0% for the India market (cap-weighted) — 3rd highest of 21 in its peer set.
Growth Revenue grew 18.4% over the last twelve months (peer median +9.1%); the operating margin is 23.7% (peer median 7.4%).
Valuation It trades at 56.7× forward earnings against a peer median of 19.2× (2nd most expensive of 18).
Price implies For today's price to make sense, revenue must grow about 36% a year for seven years (Req g). Recent delivered growth is +23%, so the hurdle is +13 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 8.7 points above its cost of capital (11.2% WACC).
Next results Next results expected around 5 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹10.9B | ₹9.87B | ₹7.84B | ₹6.44B | ₹6.07B |
| Revenue growth | — | +26% | +22% | +6% | — |
| Gross profit | ₹4.25B | ₹3.05B | ₹1.76B | ₹1.20B | ₹862M |
| EBITDA | ₹3.12B | ₹2.78B | ₹1.75B | ₹1.19B | ₹968M |
| Net income | ₹1.87B | ₹1.70B | ₹931M | ₹573M | ₹351M |
| Free cash flow | n/a | ₹321M | ₹259M | -₹92.6M | -₹181M |
| Capital expenditure | n/a | ₹1.86B | ₹722M | ₹951M | ₹1.12B |
| Total debt | ₹1.80B | ₹1.77B | ₹1.88B | ₹2.09B | ₹1.87B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Shaily Engineering Plastics SHAILY.NS | $1.48B | +14% | +18% | 24% | 56.7× | 35.8% |
| Gerresheimer GXI.DE | $1.21B | +24% | +9% | -4% | 18.0× | 55.8% |
| West Pharmaceutical Services WST | $27.9B | +23% | +13% | 23% | 39.8× | 25.2% |
| Nolato NOLA-B.ST | $1.40B | +5% | 0% | 10% | 18.8× | 3.9% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | SHAILY.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -1.3% | -16.1% | 4th highest of 21 |
| 6-month return | +13.9% | -26.3% | 3rd highest of 21 |
| Distance from 52-week high | -15.7% | -41.5% | 3rd highest of 21 |
| Revenue growth (TTM) | +18.4% | +9.1% | 6th highest of 21 |
| Operating margin | 23.7% | 7.4% | highest of 21 |
| Forward P/E | 56.7× | 19.2× | 2nd most expensive of 18 |
| Growth the price implies (Req g, 7 yrs) | 35.8% | 10.0% | 2nd most demanding of 13 |
| Growth delivered (Del g) | +22.8% | +4.3% | highest of 13 |
| Hurdle (Req g minus delivered) | +13.0 pp | +7.5 pp | 5th most demanding of 13 |
| ROIC minus cost of capital | +8.7 pp | -1.9 pp | highest of 21 |
| EV / EBITDA | 45.3× | 8.9× | most expensive of 9 |
| Net debt / EBITDA | 0.4× | 1.2× | 5th least indebted of 10 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Shaily Engineering Plastics SHAILY.NS | India | $1.48B | +14% | +18% | 24% | 56.7× | 35.8% | +22.8% |
| Anhui Wanwei Updated High-Tech Material Industry 600063.SS | China | $1.49B | -32% | +3% | 4% | 20.0× | n/a | n/a |
| KumhoPetrochem 011780.KS | South Korea | $1.50B | -37% | 0% | 7% | 4.3× | -16.5% | +7.5% |
| Denka 4061.T | Japan | $1.51B | -33% | -3% | 9% | 12.7× | n/a | n/a |
| Befar 601678.SS | China | $1.51B | -14% | +19% | 5% | 21.8× | -6.4% | +18.2% |
| Osaka Soda 4046.T | Japan | $1.52B | -2% | +8% | 19% | 13.5× | 5.1% | +0.5% |
| LOTTE CHEMICAL 011170.KS | South Korea | $1.45B | -59% | +5% | -2% | n/a | n/a | n/a |
| Elementis ELM.L | United Kingdom | $1.45B | +34% | -12% | 20% | 16.9× | 16.9% | -4.8% |
| Jilin OLED Material Tech 688378.SS | China | $1.45B | -17% | +74% | 18% | 28.1× | 46.2% | +15.2% |
| Stepan SCL | United States | $1.52B | +26% | +10% | 4% | 19.0× | 14.9% | +4.5% |
| Guangdong Orient Zirconic Industry Science & Technology 002167.SZ | China | $1.44B | +5% | +17% | 14% | 48.5× | 32.4% | +10.1% |
| Anhui Guangxin Agrochemical 603599.SS | China | $1.43B | -29% | -13% | 18% | 13.1× | -3.8% | +0.6% |
| ADAMA 000553.SZ | China | $1.55B | -33% | -6% | 3% | 30.7× | -7.2% | +0.3% |
| Proto Labs PRLB | United States | $1.57B | -5% | +12% | 8% | 27.4× | 26.8% | +4.2% |
| Shenzhen Rongda Photosensitive & Technology 300576.SZ | China | $1.40B | -31% | +14% | 10% | n/a | n/a | n/a |
| Genesis Energy, L.P GEL | United States | $1.57B | -21% | -17% | 19% | n/a | 2.2% | -2.2% |
| Shandong Dawn Polymer 002838.SZ | China | $1.40B | -35% | +31% | 6% | 19.3× | n/a | n/a |
| Guangdong Guanghua Sci-Tech 002741.SZ | China | $1.40B | -9% | +61% | 4% | 58.4× | n/a | n/a |
| Guangdong Dowstone Technology 300409.SZ | China | $1.59B | -50% | +34% | 6% | 14.0× | n/a | n/a |
| GCH Technology 688625.SS | China | $1.38B | -32% | +8% | 18% | 19.2× | 27.6% | +16.3% |
| BASF India BASF.NS | India | $1.35B | -23% | +13% | 4% | 17.4× | n/a | n/a |